Evidence map›Paper›PMID 38103786›Full record

ArticleJournal of lipid research2024

Phosphatidylthreonine is a procoagulant lipid detected in human blood and elevated in coronary artery disease.

Ali A Hajeyah, Majd B Protty, Divyani Paul, Daniela Costa, Nader Omidvar, Bethan Morgan, Yugo Iwasaki, Beth McGill, P Vincent Jenkins, Zaheer Yousef and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of lipid research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The Nanodisc System for Investigating Protein-Lipid Interactions.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  5. Article
  6. Nanodiscs for the study of membrane proteins.Current opinion in structural biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 5 countries.

Ali A HajeyahSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom; Department of Biological Sciences, Kuwait University, Safat, Kuwait. Electronic address: ali.hajeyah@ku.edu.kw.
Majd B ProttySystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Divyani PaulDepartment of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA.
Daniela CostaSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Nader OmidvarSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Bethan MorganSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Yugo IwasakiCollege of Bioscience and Biotechnology, Chubu University, Kasugai, Japan.
Beth McGillSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
P Vincent JenkinsUniversity Hospital of Wales, Cardiff, United Kingdom.
Zaheer YousefUniversity Hospital of Wales, Cardiff, United Kingdom.
Keith Allen-RedpathDepartment of Food and Nutritional Sciences, University of Reading, Reading, United Kingdom.
Shin SoyamaDepartment of Food and Nutritional Sciences, University of Reading, Reading, United Kingdom.
Anirban ChoudhuryMorriston Cardiac Centre, Swansea, United Kingdom.
Rito MitraUniversity Hospital of Wales, Cardiff, United Kingdom.
Parveen YaqoobDepartment of Food and Nutritional Sciences, University of Reading, Reading, United Kingdom.
James H MorrisseyDepartment of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA.
Peter W CollinsSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom.
Valerie B O'DonnellSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom. Electronic address: o-donnellvb@cardiff.ac.uk.
Cardiff University · GBUniversity Hospital of Wales · GBUniversity of Reading · GBUniversity of Michigan · USChubu University · JPInstitute of Infection and Immunity · CAKuwait University · KWMorriston Hospital · GB

Funding

Toolkit for High-Resolution Structure and Dynamics of Functional LipidsR01GM123455 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI MORRISSEY, JAMES H., RIENSTRA, CHAD M · 2016 to 2020
$5.0M
Mechanisms in Blood ClottingR35HL135823 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORRISSEY, JAMES H. · 2017 to 2023
$4.8M
British Heart Foundation RG/F/20/110020NHLBI NIH HHS R35 HL135823NIGMS NIH HHS R01 GM123455Wellcome Trust 216278
6 · The paper itself

Abstract

Aminophospholipids (aPL) such as phosphatidylserine are essential for supporting the activity of coagulation factors, circulating platelets, and blood cells. Phosphatidylthreonine (PT) is an aminophospholipid previously reported in eukaryotic parasites and animal cell cultures, but not yet in human tissues. Here, we evaluated whether PT is present in blood cells and characterized its ability to support coagulation. Several PT molecular species were detected in human blood, washed platelets, extracellular vesicles, and isolated leukocytes from healthy volunteers using liquid chromatography-tandem mass spectrometry. The ability of PT to support coagulation was demonstrated in vitro using biochemical and biophysical assays. In liposomes, PT supported prothrombinase activity in the presence and absence of phosphatidylserine. PT nanodiscs strongly bound FVa and lactadherin (nM affinity) but poorly bound prothrombin and FX, suggesting that PT supports prothrombinase through recruitment of FVa. PT liposomes bearing tissue factor poorly generated thrombin in platelet poor plasma, indicating that PT poorly supports extrinsic tenase activity. On platelet activation, PT is externalized and partially metabolized. Last, PT was significantly higher in platelets and extracellular vesicle from patients with coronary artery disease than in healthy controls. In summary, PT is present in human blood, binds FVa and lactadherin, supports coagulation in vitro through FVa binding, and is elevated in atherosclerotic vascular disease. Our studies reveal a new phospholipid subclass, that contributes to the procoagulant membrane, and may support thrombosis in patients at elevated risk.

Indexed as

Coronary Artery DiseaseGlycerophospholipidsThromboplastinAnimalsBlood PlateletsHumansLiposomesPhosphatidylserinesThreonineThrombinGlycerophospholipidsLiposomesPhosphatidylserinesphosphatidylthreonineThreonineThrombinThromboplastinblood coagulationcoronary artery diseasephosphatidylthreoninephospholipidsphospholipids/biosynthesisphospholipids/metabolismplateletsvascular biology

Identifiers

PMID38103786
PMCPMC10809103
OpenAlexW4389763496

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.